- Home
- PMCB vs XYLO Comparison
PMCB vs XYLO Comparison
Compare PMCB & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- XYLO
- Stock Information
- Founded
- PMCB 1996
- XYLO 1999
- Country
- PMCB United States
- XYLO Israel
- Employees
- PMCB N/A
- XYLO N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- XYLO
- Sector
- PMCB Health Care
- XYLO
- Exchange
- PMCB Nasdaq
- XYLO NYSE
- Market Cap
- PMCB 7.6M
- XYLO 6.1M
- IPO Year
- PMCB N/A
- XYLO N/A
- Fundamental
- Price
- PMCB $1.05
- XYLO $5.18
- Analyst Decision
- PMCB
- XYLO
- Analyst Count
- PMCB 0
- XYLO 0
- Target Price
- PMCB N/A
- XYLO N/A
- AVG Volume (30 Days)
- PMCB 8.5K
- XYLO 3.0K
- Earning Date
- PMCB 08-12-2025
- XYLO 07-07-2025
- Dividend Yield
- PMCB N/A
- XYLO N/A
- EPS Growth
- PMCB N/A
- XYLO N/A
- EPS
- PMCB 1.29
- XYLO N/A
- Revenue
- PMCB N/A
- XYLO $29,858,000.00
- Revenue This Year
- PMCB N/A
- XYLO $279.19
- Revenue Next Year
- PMCB N/A
- XYLO N/A
- P/E Ratio
- PMCB $0.82
- XYLO N/A
- Revenue Growth
- PMCB N/A
- XYLO N/A
- 52 Week Low
- PMCB $1.00
- XYLO $2.70
- 52 Week High
- PMCB $2.42
- XYLO $6.67
- Technical
- Relative Strength Index (RSI)
- PMCB 47.26
- XYLO 54.95
- Support Level
- PMCB $1.00
- XYLO $4.85
- Resistance Level
- PMCB $1.07
- XYLO $5.18
- Average True Range (ATR)
- PMCB 0.05
- XYLO 0.20
- MACD
- PMCB 0.01
- XYLO 0.02
- Stochastic Oscillator
- PMCB 39.78
- XYLO 92.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.